Clinical Trial Update: A Study of Mobocertinib in Japanese Adults With Non-Small Cell Lung Cancer [Phase 1]

View source ↗

Summary

Phase 1 study update of mobocertinib in Japanese adults with non-small cell lung cancer. Results have been posted and the study is currently active but not recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Mobocertinib (Exkivity) (mobocertinib)

Snippet

Sponsor: Takeda | Conditions: Non-Small Cell Lung Cancer | Phase 1 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2023-10-03